Skip to main navigation

Corporate Site Careers

MedAvail
  • Overview
  • News & Events
    • News Releases
    • Events
    • Presentations
  • Corporate Governance
    • Governance Overview
    • Board of Directors
    • Executive Management
    • Committee Composition
  • Financial Information
    • SEC Filings
    • Quarterly Results
  • Stock Information
    • Stock Quote & Chart
  • Shareholder Services
    • Investor FAQs
    • Email Alerts
    • Contact IR
X
  • Overview
  • News & Events
    • News Releases
    • Events
    • Presentations
  • Corporate Governance
    • Governance Overview
    • Board of Directors
    • Executive Management
    • Committee Composition
  • Financial Information
    • SEC Filings
    • Quarterly Results
  • Stock Information
    • Stock Quote & Chart
  • Shareholder Services
    • Investor FAQs
    • Email Alerts
    • Contact IR
MedAvail

Release Details

MedAvail to Report 2022 Second Quarter Financial Results on August 11, 2022

July 28, 2022
PDF Version

MISSISSAUGA, Ontario & PHOENIX--(BUSINESS WIRE)-- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”) a technology-enabled pharmacy company, today announced it will report financial results for the second quarter of 2022 on Thursday, August 11, 2022, after market close. MedAvail management will be webcasting a corresponding conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Live audio of the webcast will be available on the “Investor Relations” section of MedAvail’s website at: https://investors.medavail.com. The webcast will be archived and available for replay after the event.

About MedAvail

MedAvail Holdings, Inc. (NASDAQ: MDVL) is a technology-enabled pharmacy organization, providing turnkey in-clinic pharmacy services through its proprietary robotic dispensing platform, the MedAvail MedCenter, and home delivery operations, to Medicare clinics. MedAvail helps patients to optimize drug adherence, resulting in better health outcomes. Learn more at www.medavail.com.

About SpotRx

SpotRx places control of the pharmacy experience back in the hands of consumers. SpotRx is a telehealth platform that delivers remote pharmacist consultations through an on-site dispensing kiosk, supplemented with home delivery capability.

SOURCE MedAvail Holdings, Inc.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220728005184/en/

Investor Relations
Caroline Paul
Gilmartin Group
ir@medavail.com

Source: MedAvail Holdings Inc.

MedAvail

1.877.830.0826
info@medavail.com
ir@medavail.com

Home office:
4720 E. Cotton Gin Loop
Suite 220
Phoenix, AZ 85040

Canada office:
6665 Millcreek Dr. Unit 1
Mississauga, ON L5N 5M4 Canada

  • For pharmacies
  • For physician groups
  • The MedCenter
  • Partners
  • Investor Relations
  • About MedAvail
  • Careers
  • In the news
  • Contact MedAvail

Sorry. You must be logged in to view this form.

Footer Nav 2

  • Regulatory Compliance
  • Privacy Policy
  • Patent and Trademark Notice
  • Accessibility
Menu

© 2023 MedAvail Technologies, Inc. All rights reserved.